SATT AxLR
SATT AxLR
Governance
Services for companies
Annual reports
Assisting you
Researchers
Call-for-projects
Companies
Startups
Practical guide
Technology offerings
Invest
In our technologies
In our startups
Technologies
Startups
AxLR TV
Working with AxLR
Purchasing & public procurement
Join us
Our startups are hiring
Media
News
Agenda
Press kit
Communication kit
Contact
✕
Home
Marketed technology
MARKETED TECHNOLOGY |
Gene therapy – Nontraumatic intraneural injection – CMT1A
GeniaTer-CMT1A
En savoir +
GeniaTer-CMT1A
0
MARKETED TECHNOLOGY | Gene therapy – Nontraumatic intraneural injection – CMT1A
HPCG
En savoir +
HPCG
1
MARKETED TECHNOLOGY I Genetic variations
TELE-MOUV
En savoir +
TELE-MOUV
3
MARKETED TECHNOLOGY I Chronic diseases – Telemedicine
TerriStories®
En savoir +
TerriStories®
2
MARKETED TECHNOLOGY I Simulation game
ION EX
En savoir +
ION EX
4
MARKETED TECHNOLOGY I Pollution – Anionic contaminants
SILEXE
En savoir +
SILEXE
3
MARKETED TECHNOLOGY I Strategic metal – Recycle
CELDI
En savoir +
CELDI
3
MARKETED TECHNOLOGY I Reaction – Solid – Fluid – Gaz
DIVINS
En savoir +
DIVINS
4
START-UP I Aneurysms